DEA Shows No Interest in Helping States Prepare for Marijuana Rescheduling, California Official Says

California's top marijuana regulator has criticized the Drug Enforcement Administration for failing to provide implementation guidance on the Trump administration's marijuana rescheduling decision. While the DEA has not offered formal updates or cooperative support to help states navigate the regulatory implications, the federal agency simultaneously requests that California share detailed information about its medical cannabis program. This lack of coordination creates significant uncertainty for state regulators, healthcare providers, and patients relying on legal medical marijuana access. The situation highlights the ongoing disconnect between federal policy changes and state-level preparation efforts.